Transmembrane Helices 7 and 8 Confer Aggregation Sensitivity to the Cystic Fibrosis Transmembrane Conductance Regulator
暂无分享,去创建一个
G. Tartaglia | I. Braakman | Michele Monti | B. Kleizen | Peter van der Sluijs | Eduardo de Mattos | Olga Papaioannou
[1] G. Tartaglia,et al. A Computational Approach Reveals the Ability of Amyloids to Sequester RNA: the Alpha Synuclein Case , 2023, bioRxiv.
[2] M. Niemi,et al. Novel inhibitors of breast cancer resistance protein (BCRP, ABCG2) among marketed drugs. , 2022, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[3] D. Hebert,et al. Calnexin reveals a sugar‐free taste within the lipid bilayer , 2022, The EMBO journal.
[4] R. Hegde,et al. Substrate-driven assembly of a translocon for multipass membrane proteins , 2022, Nature.
[5] R. Hegde,et al. Mechanism of an intramembrane chaperone for multipass membrane proteins , 2022, Nature.
[6] J. Mornon,et al. Digging into the 3D Structure Predictions of AlphaFold2 with Low Confidence: Disorder and Beyond , 2022, Biomolecules.
[7] P. van der Sluijs,et al. Redefining Hypo- and Hyper-Responding Phenotypes of CFTR Mutants for Understanding and Therapy , 2022, bioRxiv.
[8] E. Park,et al. Mechanism of Protein Translocation by the Sec61 Translocon Complex. , 2022, Cold Spring Harbor perspectives in biology.
[9] P. van der Sluijs,et al. ABC-transporter CFTR folds with high fidelity through a modular, stepwise pathway , 2022, bioRxiv.
[10] Matthias J. Feige,et al. Intramembrane client recognition potentiates the chaperone functions of calnexin , 2022, bioRxiv.
[11] M. Reichelt,et al. A membrane protein display platform for receptor interactome discovery , 2021, Proceedings of the National Academy of Sciences.
[12] R. Pappu,et al. AlphaFold and implications for intrinsically disordered proteins. , 2021, Journal of molecular biology.
[13] Oriol Vinyals,et al. Highly accurate protein structure prediction with AlphaFold , 2021, Nature.
[14] A. Pastore,et al. Aggregation is a Context-Dependent Constraint on Protein Evolution , 2021, bioRxiv.
[15] S. Randell,et al. DNAJB12 and Hsp70 triage arrested intermediates of N1303K-CFTR for endoplasmic reticulum-associated autophagy , 2021, Molecular biology of the cell.
[16] P. van der Sluijs,et al. Co-translational folding of the first transmembrane domain of ABC-transporter CFTR is supported by assembly with the first cytosolic domain , 2020, bioRxiv.
[17] Conrad C. Huang,et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers , 2020, Protein science : a publication of the Protein Society.
[18] A. Burlingame,et al. An ER translocon for multi-pass membrane protein biogenesis , 2020, eLife.
[19] I. Callebaut,et al. Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency , 2020, Liver international : official journal of the International Association for the Study of the Liver.
[20] A. Aksimentiev,et al. Protein unfolding by SDS: the microscopic mechanisms and the properties of the SDS-protein assembly. , 2020, Nanoscale.
[21] P. Picotti,et al. Mass spectrometry analysis of the structural proteome. , 2019, Current opinion in structural biology.
[22] B. Shoichet,et al. Structural identification of a hotspot on CFTR for potentiation , 2019, Science.
[23] X. Zou,et al. Identifying the molecular target sites for CFTR potentiators GLPG1837 and VX-770 , 2019, The Journal of general physiology.
[24] P. van der Sluijs,et al. Characterization of CNPY5 and its family members , 2019, Protein science : a publication of the Protein Society.
[25] P. Linsdell,et al. Contribution of the eighth transmembrane segment to the function of the CFTR chloride channel pore , 2019, Cellular and Molecular Life Sciences.
[26] C. Sanders,et al. Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis , 2019, Chemical reviews.
[27] Jue Chen,et al. Molecular structure of the ATP-bound, phosphorylated human CFTR , 2018, Proceedings of the National Academy of Sciences.
[28] R. Hegde,et al. EMC Is Required to Initiate Accurate Membrane Protein Topogenesis , 2018, Cell.
[29] J. Riordan,et al. Cryo-EM visualization of an active high open probability CFTR ion channel , 2018, bioRxiv.
[30] K. Conrath,et al. A common mechanism for CFTR potentiators , 2017, The Journal of general physiology.
[31] D. Tieleman,et al. Structure of Transmembrane Helix 8 and Possible Membrane Defects in CFTR , 2017, bioRxiv.
[32] J. Riordan,et al. Stabilization of a nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator yields insight into disease-causing mutations , 2017, The Journal of Biological Chemistry.
[33] C. Dobson,et al. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. , 2017, Annual review of biochemistry.
[34] D. Gadsby,et al. Molecular Structure of the Human CFTR Ion Channel , 2017, Cell.
[35] I. Callebaut,et al. Functional defect of variants in the adenosine triphosphate–binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX‐770) , 2017, Hepatology.
[36] Tudor I. Oprea,et al. A comprehensive map of molecular drug targets , 2016, Nature Reviews Drug Discovery.
[37] Jue Chen,et al. Atomic Structure of the Cystic Fibrosis Transmembrane Conductance Regulator , 2016, Cell.
[38] J. Weissman,et al. The SND proteins constitute an alternative targeting route to the endoplasmic reticulum , 2016, Nature.
[39] R. Ford,et al. The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability , 2016, Cellular and Molecular Life Sciences.
[40] Ya-xin Lou,et al. MARCH2 regulates autophagy by promoting CFTR ubiquitination and degradation and PIK3CA-AKT-MTOR signaling , 2016, Autophagy.
[41] J. Riordan,et al. Thermal stability of purified and reconstituted CFTR in a locked open channel conformation. , 2015, Protein expression and purification.
[42] L. DeLucas,et al. A survey of detergents for the purification of stable, active human cystic fibrosis transmembrane conductance regulator (CFTR). , 2014, Biochimica et biophysica acta.
[43] J. Forman-Kay,et al. Regulatory R region of the CFTR chloride channel is a dynamic integrator of phospho-dependent intra- and intermolecular interactions , 2013, Proceedings of the National Academy of Sciences.
[44] D. Clarke,et al. Corrector VX-809 stabilizes the first transmembrane domain of CFTR. , 2013, Biochemical pharmacology.
[45] D. Duan,et al. Regulation of Activation and Processing of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by a Complex Electrostatic Interaction between the Regulatory Domain and Cytoplasmic Loop 3* , 2012, The Journal of Biological Chemistry.
[46] D. Clarke,et al. Corrector-mediated rescue of misprocessed CFTR mutants can be reduced by the P-glycoprotein drug pump. , 2012, Biochemical pharmacology.
[47] K. Du,et al. Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function , 2012, Cell.
[48] Philip J. Thomas,et al. Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences , 2012, Cell.
[49] Philip J. Thomas,et al. The Primary Folding Defect and Rescue of ΔF508 CFTR Emerge during Translation of the Mutant Domain , 2010, PloS one.
[50] Julie D Forman-Kay,et al. NMR evidence for differential phosphorylation‐dependent interactions in WT and ΔF508 CFTR , 2010, The EMBO journal.
[51] J. Riordan,et al. Architecture of the cystic fibrosis transmembrane conductance regulator protein and structural changes associated with phosphorylation and nucleotide binding. , 2009, Journal of structural biology.
[52] G. von Heijne,et al. Membrane-integration characteristics of two ABC transporters, CFTR and P-glycoprotein. , 2009, Journal of molecular biology.
[53] G. Lukács,et al. N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic , 2009, The Journal of cell biology.
[54] W. Skach,et al. Sequence-specific retention and regulated integration of a nascent membrane protein by the endoplasmic reticulum Sec61 translocon. , 2008, Molecular biology of the cell.
[55] A. Evagelidis,et al. PKC phosphorylation modulates PKA-dependent binding of the R domain to other domains of CFTR. , 2008, American journal of physiology. Cell physiology.
[56] D. Cyr,et al. Assembly and misassembly of cystic fibrosis transmembrane conductance regulator: folding defects caused by deletion of F508 occur before and after the calnexin-dependent association of membrane spanning domain (MSD) 1 and MSD2. , 2008, Molecular biology of the cell.
[57] Blanche Schwappach,et al. The GET Complex Mediates Insertion of Tail-Anchored Proteins into the ER Membrane , 2008, Cell.
[58] Michele Vendruscolo,et al. Prediction of aggregation-prone regions in structured proteins. , 2008, Journal of molecular biology.
[59] M. Vendruscolo,et al. The Zyggregator method for predicting protein aggregation propensities. , 2008, Chemical Society reviews.
[60] B. Wang,et al. BAP31 Interacts with Sec61 Translocons and Promotes Retrotranslocation of CFTRΔF508 via the Derlin-1 Complex , 2008, Cell.
[61] J. Riordan,et al. CFTR function and prospects for therapy. , 2008, Annual review of biochemistry.
[62] G. Heijne,et al. Molecular code for transmembrane-helix recognition by the Sec61 translocon , 2007, Nature.
[63] J. Forman-Kay,et al. CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices , 2007, Nature Structural &Molecular Biology.
[64] G. Cutting,et al. The CFTR-derived peptides as a model of sequence-specific protein aggregation , 2007, Cellular & Molecular Biology Letters.
[65] Andrei Aleksandrov,et al. Domain interdependence in the biosynthetic assembly of CFTR. , 2007, Journal of molecular biology.
[66] I. Braakman,et al. Folding of CFTR is predominantly cotranslational. , 2005, Molecular cell.
[67] M. Amaral,et al. Most F508del-CFTR Is Targeted to Degradation at an Early Folding Checkpoint and Independently of Calnexin , 2005, Molecular and Cellular Biology.
[68] Dmitrij Frishman,et al. STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins , 2004, Nucleic Acids Res..
[69] J. Wakefield,et al. Efficient Intracellular Processing of the Endogenous Cystic Fibrosis Transmembrane Conductance Regulator in Epithelial Cell Lines* , 2004, Journal of Biological Chemistry.
[70] B. Papsin,et al. Misfolding diverts CFTR from recycling to degradation , 2004, The Journal of cell biology.
[71] Christopher M Dobson,et al. Principles of protein folding, misfolding and aggregation. , 2004, Seminars in cell & developmental biology.
[72] S. Dhani,et al. Stable dimeric assembly of the second membrane-spanning domain of CFTR (cystic fibrosis transmembrane conductance regulator) reconstitutes a chloride-selective pore. , 2003, The Biochemical journal.
[73] H. Hauri,et al. A high-molecular-weight complex of membrane proteins BAP29/BAP31 is involved in the retention of membrane-bound IgD in the endoplasmic reticulum , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[74] S. High,et al. Role of calnexin in the glycan‐independent quality control of proteolipid protein , 2003, The EMBO journal.
[75] D. Thirumalai,et al. Emerging ideas on the molecular basis of protein and peptide aggregation. , 2003, Current opinion in structural biology.
[76] W. Skach,et al. Cooperativity and Flexibility of Cystic Fibrosis Transmembrane Conductance Regulator Transmembrane Segments Participate in Membrane Localization of a Charged Residue* , 2002, The Journal of Biological Chemistry.
[77] L. Berthiaume,et al. Properties of the Na+/H+ exchanger protein. Detergent-resistant aggregation and membrane microdistribution. , 2002, European journal of biochemistry.
[78] G. Cutting,et al. Aggregation of Misfolded Proteins Can Be a Selective Process Dependent upon Peptide Composition* , 2002, The Journal of Biological Chemistry.
[79] A. Helenius,et al. ER quality control: towards an understanding at the molecular level. , 2001, Current opinion in cell biology.
[80] M. Reth,et al. Control of Cystic Fibrosis Transmembrane Conductance Regulator Expression by BAP31* , 2001, The Journal of Biological Chemistry.
[81] P. Cresswell,et al. Quality control of transmembrane domain assembly in the tetraspanin CD82 , 2001, The EMBO journal.
[82] G. Lukács,et al. Conformational and Temperature-sensitive Stability Defects of the ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator in Post-endoplasmic Reticulum Compartments* , 2001, The Journal of Biological Chemistry.
[83] G. Cutting,et al. A PDZ-binding motif is essential but not sufficient to localize the C terminus of CFTR to the apical membrane. , 2001, Journal of cell science.
[84] Ming-Ming Zhou. Phosphothreonine recognition comes into focus , 2000, Nature Structural Biology.
[85] H. Perreault,et al. Secondary structure and oligomerization of the E. coli glycerol facilitator. , 2000, Biochemistry.
[86] I. Braakman,et al. The CXXCXXC motif determines the folding, structure and stability of human Ero1‐Lα , 2000, The EMBO journal.
[87] King Sa,et al. R-domain interactions with distal regions of CFTR lead to phosphorylation and activation. , 2000 .
[88] Michele C. Kieke,et al. Directed evolution of a stable scaffold for T-cell receptor engineering , 2000, Nature Biotechnology.
[89] A. D. Robertson,et al. A functional R domain from cystic fibrosis transmembrane conductance regulator is predominantly unstructured in solution. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[90] William F. DeGrado,et al. Asparagine-mediated self-association of a model transmembrane helix , 2000, Nature Structural Biology.
[91] F. Hartl,et al. An unstable transmembrane segment in the cystic fibrosis transmembrane conductance regulator , 1999, The EMBO journal.
[92] J. Blalock,et al. CFTR chloride channel regulation by an interdomain interaction. , 1999, Science.
[93] K D Wittrup,et al. Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency. , 1999, Journal of molecular biology.
[94] Min Goo Lee,et al. Dynamic Association of Proteasomal Machinery with the Centrosome , 1999, The Journal of cell biology.
[95] D. Cyr,et al. The Hdj‐2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis , 1999, The EMBO journal.
[96] R. Kopito,et al. Aggresomes: A Cellular Response to Misfolded Proteins , 1998, The Journal of cell biology.
[97] P. Sluijs,et al. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. , 1998, The Journal of clinical investigation.
[98] G. Lukács,et al. Limited proteolysis as a probe for arrested conformational maturation of ΔF508 CFTR , 1998, Nature Structural Biology.
[99] S. Hubbard,et al. The structural aspects of limited proteolysis of native proteins. , 1998, Biochimica et biophysica acta.
[100] J. Widdicombe,et al. Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator. , 1997, The Journal of clinical investigation.
[101] M. Welsh,et al. Association of domains within the cystic fibrosis transmembrane conductance regulator. , 1997, Biochemistry.
[102] J. Henry,et al. SDS-resistant aggregation of membrane proteins: application to the purification of the vesicular monoamine transporter. , 1996, The Biochemical journal.
[103] Satoshi Omura,et al. Degradation of CFTR by the ubiquitin-proteasome pathway , 1995, Cell.
[104] J. Riordan,et al. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing , 1995, Cell.
[105] S. High,et al. The translocation, folding, assembly and redox-dependent degradation of secretory and membrane proteins in semi-permeabilized mammalian cells. , 1995, The Biochemical journal.
[106] J. Riordan,et al. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. , 1994, The Journal of biological chemistry.
[107] M. Welsh,et al. The amino-terminal portion of CFTR forms a regulated CI− channel , 1994, Cell.
[108] P. Greengard,et al. Phosphorylation of the cystic fibrosis transmembrane conductance regulator. , 1992, The Journal of biological chemistry.
[109] H. Hobbs,et al. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. , 1990, Annual review of genetics.
[110] L. Tsui,et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. , 1989, Science.
[111] R. Doolittle,et al. A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.
[112] C. Tanford,et al. Characterization of membrane proteins in detergent solutions. , 1976, Biochimica et biophysica acta.
[113] Kai Du,et al. The ΔF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR , 2005, Nature Structural &Molecular Biology.
[114] J. Riordan,et al. A novel CFTR disease-associated mutation causes addition of an extra N-linked oligosaccharide , 2004, Glycoconjugate Journal.
[115] P. Picotti,et al. Probing protein structure by limited proteolysis. , 2004, Acta biochimica Polonica.
[116] D. Engelman,et al. Helical membrane protein folding, stability, and evolution. , 2000, Annual review of biochemistry.
[117] W. Wimley,et al. Membrane protein folding and stability: physical principles. , 1999, Annual review of biophysics and biomolecular structure.
[118] J. Riordan. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA , 1989 .